← All Sponsors
SPONSOR

Rahul Aggarwal

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2

Rahul Aggarwal is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Prostate Cancer, Renal Cancer, Urethral Cancer, Advanced Solid Tumor.

The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Rahul Aggarwal

How many clinical trials has Rahul Aggarwal sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Rahul Aggarwal, of which 1 are actively recruiting participants. These trials cover conditions including Prostate Cancer, Renal Cancer, Urethral Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Rahul Aggarwal research focus on?
Rahul Aggarwal clinical trials span Prostate Cancer, Renal Cancer, Urethral Cancer, Advanced Solid Tumor, Metastatic Castration-resistant Prostate Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Rahul Aggarwal clinical trial?
To participate in a Rahul Aggarwal trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rahul Aggarwal trials with current recruitment status updated daily.

Clinical Trials by Rahul Aggarwal

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology